Dergiler / Journal of the Turkish Chemical Society Section A: Chemistry / 2021 / Cilt: 8 - Sayı: 2

The Compound Specific Antibacterial Activities of Major Urolithins and Their Methyl Ethers

Sayfa
579–584
Yayın Tarihi
2021-05-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition, the antagonist effect of some compounds on the antibacterial action of standard molecules also pointed out the compound-specific activities of the title molecules.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The investigation of biological activities of natural products, particularly considering the secondary metabolites, continuously receives attention.
📊
Temel Bulgular & Veri:Urolithins, the bioavailable metabolites of ellagitannins, were shown to possess enzyme inhibitor, antioxidant, and anti-inflammatory compounds in scientific studies conducted in the last two decades.
💡
Sonuç & Katkı:In addition, the antagonist effect of some compounds on the antibacterial action of standard molecules also pointed out the compound-specific activities of the title molecules.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Urolithin · synthesis · antibacterial activity

Abstract

The investigation of biological activities of natural products, particularly considering the secondary metabolites, continuously receives attention. Urolithins, the bioavailable metabolites of ellagitannins, were shown to possess enzyme inhibitor, antioxidant, and anti-inflammatory compounds in scientific studies conducted in the last two decades. Regarding the limited number of studies related to their antimicrobial activity, this study aimed to synthesize major urolithins (Urolithin A and B) concomitant to their methyl ether derivatives and screen their antibacterial activity against some Gram-positive and Gram-negative bacteria. In parallel to the antibacterial activity, the synergistic and antagonist properties of the compounds were also analyzed in the presence of reference beta-lactam antibiotics. The results displayed the improvable characteristics of urolithin scaffold to be employed in antibiotic drug design studies. In addition, the antagonist effect of some compounds on the antibacterial action of standard molecules also pointed out the compound-specific activities of the title molecules.

🔖

Bu Makaleye Atıf Yap

GÜLCAN, H. O., İLKTAÇ, M., NOSHADİ, B., SHUKUR, K., GAZİ, M. (2021). The Compound Specific Antibacterial Activities of Major Urolithins and Their Methyl Ethers. Journal of the Turkish Chemical Society Section A: Chemistry, Cilt: 8 - Sayı: 2, 579–584. https://ajindex.com/articles/781140

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nature reviews Drug discovery. 2005 Mar;4(3):206-20
  2. Ji HF, Li XJ, Zhang HY. Natural products and drug discovery: can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?. EMBO reports. 2009 Mar;10(3):194-200
  3. Wöll S, Kim SH, Greten HJ, Efferth T. Animal plant warfare and secondary metabolite evolution. Natural products and bioprospecting. 2013 Feb 1;3(1):1-7
  4. Pathan H, Williams J. Basic opioid pharmacology: an update. British journal of pain. 2012 Feb;6(1):11-6
  5. Demain AL, Sanchez S. Microbial drug discovery: 80 years of progress. The Journal of antibiotics. 2009 Jan;62(1):5-16
  6. Gulcan HO, Unlu S, Esiringu İ, Ercetin T, Sahin Y, Oz D, Sahin MF. Design, synthesis and biological evaluation of novel 6H-benzo [c] chromen-6-one, and 7, 8, 9, 10-tetrahydro-benzo [c] chromen-6-one derivatives as potential cholinesterase inhibitors. Bioorganic & medicinal chemistry. 2014 Oct 1;22(19):5141-54
  7. Selma MV, Beltrán D, García-Villalba R, Espín JC, Tomás-Barberán FA. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. Food & function. 2014;5(8):1779-84
  8. Gonzalez-Barrio R, Truchado P, Ito H, Espin JC, Tomas-Barberan FA. UV and MS identification of urolithins and nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals. Journal of Agricultural and Food Chemistry. 2011 Feb 23;59(4):1152-62
  9. Landete JM. Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food research international. 2011 Jun 1;44(5):1150-60
  10. Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. The Journal of nutrition. 2006 Oct 1;136(10):2481-5
  11. Lipińska L, Klewicka E, Sójka M. The structure, occurrence and biological activity of ellagitannins: a general review. Acta Scientiarum Polonorum Technologia Alimentaria. 2014 Sep 30;13(3):289-99
  12. Ammar OM, Ilktac M, Gulcan HO. Urolithins and their antimicrobial activity: A short review. EMU Journal of Pharmaceutical Sciences. 2019;3(2):117-24
  13. Giménez-Bastida JA, Truchado P, Larrosa M, Espín JC, Tomás-Barberán FA, Allende A, García-Conesa MT. Urolithins, ellagitannin metabolites produced b